US Top News and Analysis

Novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysis

October 20, 2026 at 04:11 PM

Novo released new evidence that its experimental CagriSema injection can improve upon the weight loss with its blockbuster GLP-1 obesity injection, Wegovy.

Shown as published in the source's RSS feed. IndiaAIFounders doesn't link out to third-party sites — this is the complete detail available from the feed itself.